Index Entries

Stephanie Seneff
February 2022

82 minute video

Stephanie Seneff is a senior research scientist at the MIT Computer Science and Artificial Intelligence Laboratory.

Interviewed by Joseph Mercola.

Seneff: “It’s just amazing, because [reports of cancer are] overall two times [higher]. Breast cancer, for example, is three times [higher] for these vaccines in one year, as they are for all the other vaccines for 31 years. It’s a hugely strong signal.

Lymphoma is also showing up much more frequently with these [COVID shots]. There’s just an amazing signal there in VAERS [the U.S. Vaccine Adverse Events Reporting System]…

It’s ironic that the vaccines are being given to protect you from COVID, yet, they produce a situation where your immune cells are ill-equipped to fight SARS-CoV-2 if it gets into the cell…

The immune cells take up the nanoparticles and carry them through the lymph system into the spleen. Multiple studies have shown that it ends up in the spleen … the ovaries, the liver, the bone marrow … The spleen, of course, is very important for producing antibodies…

It’s as if the human immune cells suddenly decided to make a really toxic protein, and make lots of it — which is exactly what they’re doing — and the immune system is completely baffled by this. The immune cells have no clue what to do with it.

Of course, these immune cells that are overloaded with all this spike protein, they say, ‘I’ve got to get rid of this stuff,’ so they ship it out as these exosomes. The microRNAs [in the exosomes] think that the recipient cells are going to need those particular signaling molecules to help it do whatever it needs to do to cope with this toxic load.

After something like 14 days of the second [jab], the exosomes induced an antibody response. [The researchers] felt the exosomes played a critical role in this extreme antibody response that was produced by the B-cells and the T-cells, the adaptive immune system…

There’s a crossover point at which the enhancing antibodies can be stronger than the protective antibodies, and that’s when you can get this antibody dependent enhancement (ADE) that people have seen in the past with [other] coronavirus vaccines. We’re still trying to see if that’s the case with [the COVID jabs]. There is some evidence here and there, but it’s not [conclusive yet]…

Kanduc has written a lot about this. She’s an expert on these antibodies … The [SARS-CoV-2] spike protein is very overlapped with human protein. That means when you build a really strong antibody response to the spike protein, those antibodies can get confused and they can attack a human protein that has a similar sequence.

That’s a classic form of autoimmune disease. It’s called molecular mimicry. There were many different proteins that matched. It was quite surprising … It seems to be very well designed to induce autoimmune disease, if you produce antibodies to those sequences in the spike protein…

I think we’re going to see people getting these neurodegenerative diseases earlier and earlier in life than they used to, and I think anybody who already has any of these diseases is going to have accelerated progression

In the first paper that Greg and I wrote, we predicted the vaccines would cause an increased emergence of variants of spike protein, altered versions of the virus, under the pressure of the vaccine. Indeed, it looks to me like that’s what’s happening.”

video
adverse events,adverse-event reporting systems,cancer,COVID-19,mRNA,neurological disorders,SARS-CoV-2 spike protein,vaccines